Dubai, UAE October 7, 2024: Scigeniq is pleased to announce it has evolved its partnership with ValGenesis from Service Partner to Excellence Partner, allowing it to take on a more active role in the sales, configuration, and implementation of ValGenesis’s flagship product, Validation Life Cycle Management Solution (“VLMS”).
Scigeniq provides unique solutions that guide customers’ digital modernization and transformation journeys, helping customers gain improvements in their quality, regulatory, content, and manufacturing management processes.
As an Excellence Partner, Scigeniq can sell VLMS licenses to customers and provide configuration and implementation support. Scigeniq will also implement VLMS in its own operations to ensure greater efficiency.
“We are very excited about extending our strategic partnership with ValGenesis to cover commercial excellence. This enhanced partnership will allow us not only to implement ValGenesis VLMS in our own operations but offer a great solution for our customers that will help streamline and expedite their validation activities and documentation in a much more compliant manner,” said Abdullah Othman, Scigeniq Chief Quality and Product Officer.
ValGenesis is the industry innovator of digitized validation. The company’s platform, which includes its flagship VLMS offering, is used in over 100,000 GMP systems worldwide, helping life sciences companies advance their digital transformation strategy, enforce compliance, and enable standardization with 100% digital, risk-based validation software.
“With Scigenic as our Excellence Partner, clients across MENA can now leverage ValGenesis’ market-leading digital validation solutions directly through Scigenic’s expertise,” says Bo Olsen, ValGenesis’ SVP of Partners. “This partnership ensures that organizations in the region can adopt cutting-edge validation technology, driving compliance, efficiency, and innovation in their digital transformation journey.”
ABOUT SCIGENIQ
Scigeniq is deeply committed to helping customers leverage world-class software solutions to drive dramatic improvements in quality, regulatory, and content-management processes. The company has a full suite of quality, training, document and asset management, and regulatory solutions to automate and optimize end-to-end processes and deliver maximum impact. With decades of experience with some of the largest and best-known pharma companies in the MENA and North Africa, Scigeniq brings best practices and a pragmatic perspective to every customer’s implementation of their solutions. For more information, visit: https://scigeniq.com/
ABOUT VALGENESIS
ValGenesis, Inc. is the creator of an innovative software platform that serves as a foundation for managing compliance-based validation activities in life science companies. ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. As the first fully paperless solution for electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005. For more information, visit https://www.valgenesis.com/
Further Information
Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026, althea.dsylva@valgenesis.com
Barb Mosher Zinck, Scigeniq Marketing, barb.m.zinck@scigeniq.com